Insulin Glargine,hum.Rec.Anlog
Brand name: Lantus Solostar
Rank #8 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$1.94B
Total Cost
3,118,259
Total Claims
$1.94B
Total Cost
95,669
Prescribers
$622
Cost per Claim
452,927
Beneficiaries
5,459,707
30-Day Fills
$20K
Avg Cost/Provider
33
Avg Claims/Provider
Share of Medicare Part D Spending
0.70%
of total Medicare Part D spending
$1.94B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $1.94B total
🔎 Data Overview
Insulin Glargine,hum.Rec.Anlog is the #8 most expensive drug in Medicare Part D, costing taxpayers $1.94B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Insulin Glargine,hum.Rec.Anlog
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Carlos Rivera | Endocrinology | Miami, FL | 1,228 | $777K |
| 2 | Hasan Qutob | Endocrinology | Jackson, MI | 814 | $730K |
| 3 | Brian Burtch | Endocrinology | Mentor, OH | 565 | $633K |
| 4 | Robert Bingham | Endocrinology | Rochester, NY | 762 | $626K |
| 5 | Natasha Rodriguez | Physician Assistant | Chicopee, MA | 836 | $617K |
| 6 | Nadia Khoury | Endocrinology | Southgate, MI | 486 | $617K |
| 7 | Haleh Haerian | Endocrinology | Altoona, PA | 734 | $589K |
| 8 | Francis Arce | Internal Medicine | Oswego, NY | 442 | $587K |
| 9 | Vasdev Lohano | Endocrinology | Washington, IN | 776 | $575K |
| 10 | Nidhi Jain | Endocrinology | Little Rock, AR | 823 | $571K |
| 11 | Miguel Parilo | Endocrinology | Dayton, OH | 488 | $565K |
| 12 | Steven Cowart | Endocrinology | Huntsville, AL | 645 | $542K |
| 13 | Ahmed Al Jebawi | Endocrinology | Anderson, IN | 625 | $537K |
| 14 | Steven Bielski | Endocrinology | Geneva, IL | 505 | $535K |
| 15 | Jennifer Argumedo | Endocrinology | San Antonio, TX | 376 | $511K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
| 7 | Lenalidomide (Revlimid) | $2.15B | 130,834 |
| 8 | Insulin Glargine,hum.Rec.Anlog (Lantus Solostar) | $1.94B | 3,118,259 |
| 9 | Fluticasone/Umeclidin/Vilanter (Trelegy Ellipta) | $1.81B | 2,046,216 |
| 10 | Dapagliflozin Propanediol (Farxiga) | $1.65B | 1,666,200 |
| 11 | Sitagliptin Phosphate (Januvia) | $1.54B | 1,567,668 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology